First Trust Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $29.8M | Buy |
|
|||||
|
2022
Q1 | $23.7M | Buy |
|
|||||
|
2021
Q4 | $46.2M | Sell |
|
|||||
|
2021
Q3 | $68.2M | Buy |
|
|||||
|
2021
Q2 | $55.9M | Sell |
|
|||||
|
2021
Q1 | $83M | Buy |
|
|||||
|
2020
Q4 | $64.8M | Buy |
|
|||||
|
2020
Q3 | $50.1M | Sell |
|
|||||
|
2020
Q2 | $78.7M | Buy |
|
|||||
|
2020
Q1 | $45.1M | Sell |
|
|||||
|
2019
Q4 | $64.1M | Buy |
|
|||||
|
2019
Q3 | $48.4M | Sell |
|
|||||
|
2019
Q2 | $107M | Buy |
|
|||||
|
2019
Q1 | $72.2M | Sell |
|
|||||
|
2018
Q4 | $75.9M | Buy |
|
|||||
|
2018
Q3 | $126M | Buy |
|
|||||
|
2018
Q2 | $36.6M | Buy |
|
|||||
|
2018
Q1 | $77.8M | Sell |
|
|||||
|
2017
Q4 | $102M | Buy |
|
|||||
|
2017
Q3 | $39.7M | Sell |
|
|||||
|
2017
Q2 | $33.9M | Sell |
|
|||||
|
2017
Q1 | $52.8M | Buy |
|
|||||
|
2016
Q4 | $25.6M | Buy |
|
|||||
|
2016
Q3 | $30.2M | Sell |
|
|||||
|
2016
Q2 | $27.8M | Sell |
|
|||||
|
2016
Q1 | $30.8M | Sell |
|
|||||
|
2015
Q4 | $162M | Sell |
|
|||||
|
2015
Q3 | $114M | Buy |
|
|||||
|
2015
Q2 | $122M | Buy |
|
|||||
|
2015
Q1 | $69.4M | Buy |
|
|||||
|
2014
Q4 | $77.7M | Sell |
|
|||||
|
2014
Q3 | $74.1M | Buy |
|
|||||
|
2014
Q2 | $67.4M | Buy |
|
|||||
|
2014
Q1 | $54.1M | Buy |
|
|||||
|
2013
Q4 | $49M | Buy |
|
|||||
|
2013
Q3 | $32.6M | Buy |
|
|||||
|
2013
Q2 | $25.8M | Buy |
|